BRIEF published on 04/20/2026 at 17:54, 1 month 3 days ago ONWARD Medical clôture un placement privé et lève 40,6 millions d'euros. Euronext Placement Privé ONWARD Medical Thérapie De La Moelle Épinière Neurotechnologie
BRIEF published on 04/20/2026 at 17:54, 1 month 3 days ago ONWARD Medical Concludes Private Placement Raising EUR 40.6M Private Placement Euronext Neurotechnology ONWARD Medical Spinal Cord Therapy
PRESS RELEASE published on 04/20/2026 at 17:49, 1 month 3 days ago ONWARD Medical Publishes Closing of Bookbuild Offering ONWARD Medical N.V. announces closing of EUR 40.6M Private Placement with institutional investors, new shares listed on Euronext. Company pioneering neurotechnology therapies for spinal cord injuries and movement disabilities Private Placement Euronext Neurotechnology ONWARD Medical Spinal Cord Injuries
BRIEF published on 04/16/2026 at 07:39, 1 month 7 days ago ONWARD Medical obtient une augmentation de capital de plus de 40 millions d'euros Augmentation De Capital ONWARD Medical Neurotechnologie Lésions De La Moelle Épinière EQT Sciences De La Vie
BRIEF published on 04/16/2026 at 07:39, 1 month 7 days ago ONWARD Medical Secures Over EUR 40 Million in Capital Increase EQT Life Sciences Capital Increase Neurotechnology ONWARD Medical Spinal Cord Injuries
PRESS RELEASE published on 04/16/2026 at 07:34, 1 month 7 days ago ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase ONWARD Medical successfully raises over EUR 40 million in capital increase, with EUR 25.0M investment from EQT Life Sciences. Cash runway extended into Q1 2028 EQT Life Sciences Capital Increase Neurotechnology ONWARD Medical Spinal Cord Injuries
BRIEF published on 04/01/2026 at 08:53, 1 month 22 days ago ONWARD Medical Convenes 2026 AGM in Amsterdam Shareholder Resolutions Amsterdam ONWARD Medical AGM 2026 Spinal Cord Therapies
BRIEF published on 04/01/2026 at 08:53, 1 month 22 days ago ONWARD Medical tiendra son assemblée générale annuelle 2026 à Amsterdam. Amsterdam Résolutions Des Actionnaires ONWARD Medical Assemblée Générale Annuelle 2026 Thérapies De La Moelle Épinière
PRESS RELEASE published on 04/01/2026 at 08:48, 1 month 22 days ago ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions ONWARD Medical convokes the 2026 AGM of Shareholders in Amsterdam, proposing resolutions including financial report discussion and director appointments Shareholders Resolutions Neurotechnology ONWARD Medical 2026 AGM
BRIEF published on 03/31/2026 at 07:50, 1 month 23 days ago ONWARD Medical's 2025 Performance and Pipeline Developments Financial Results Regulatory Milestones ONWARD Medical ARC-EX System Commercial Performance
Published on 05/23/2026 at 19:45, 5 hours 1 minute ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 21 hours 31 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 21 hours 46 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 22 hours 21 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 22 hours 21 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 16:30, 8 hours 15 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 8 hours 49 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 2 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 1 day 2 hours ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 1 day 4 hours ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 19:35, 1 day 5 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 6 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 6 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 11 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 11 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
